loading page

An unusual presentation of Sweet syndrome in a patient with ulcerative colitis treated with a tumor necrosis factor alpha inhibitor: a case report
  • Yung-Chun Chang,
  • Hui-Ju Yang
Yung-Chun Chang
Changhua Christian Hospital
Author Profile
Hui-Ju Yang
Chung Shan Medical University
Author Profile

Abstract

Tumor necrosis factor (TNF) alpha inhibitors are widely used to treat inflammatory bowel disease (IBD) and Sweet syndrome is known as an extra-intestinal cutaneous manifestation of IBD. We wish to highlight a paradoxical case and successful management of anti-TNF-agent-induced Sweet syndrome compared with Sweet syndrome treated by anti-TNF agents.